Form 4: SEC Form 4: Patel Acquires Exzeo Group Stock
Insider Transaction Report
Paresh Patel, CEO and Director of Exzeo Group, Inc., reported the acquisition of 2,000 shares of common stock and disclosed details of a stock option grant.
Summary
- Paresh Patel, Chief Executive Officer and Director of Exzeo Group, Inc. (XZO), acquired 2,000 shares of common stock on April 24, 2026, at a price of $16.21 per share.
- Following this transaction, Mr. Patel beneficially owns 1,628,013 shares of common stock directly.
- The filing also provides details on a stock option granted on October 1, 2021, allowing the purchase of 5,000,000 shares of common stock at an exercise price of $23 per share.
- This option vests quarterly, with one-fourth vesting on October 1, 2022, and one-sixteenth vesting on subsequent January 1, April 1, July 1, and October 1 dates.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral; it reports standard insider transactions and compensation details without immediate positive or negative financial performance indicators.
Positives
- Acquisition of 2,000 common shares by the CEO and Director, indicating personal investment in the company.
- The CEO and Director holds a significant number of shares (1,628,013) directly, demonstrating substantial beneficial ownership.
- A large stock option grant (5,000,000 shares) is in place, potentially aligning management's long-term interests with shareholder value, subject to vesting schedules.
Negatives
- The exercise price of the stock option ($23) is higher than the current market price implied by the recent stock acquisition ($16.21), suggesting the options are currently out-of-the-money.
Risks
- The stock options are currently out-of-the-money, which could impact employee motivation or retention if the stock price does not appreciate sufficiently.
- The vesting schedule for the stock options is spread over several years, meaning the full benefit of the grant is not immediately realized.
Future Outlook
The filing details a stock option grant with a future exercise price of $23.00, implying a positive outlook from management's perspective on the company's potential to reach or exceed this valuation. The vesting schedule indicates a long-term commitment and incentive structure.
Management Comments
- The filing indicates a 10b5-1 trading plan was utilized for the transaction, suggesting a pre-arranged plan for stock sales or purchases.
- The explanation of responses clarifies the vesting schedule for the stock options, detailing the phased release of shares over time.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The acquisition of shares by a CEO and Director, coupled with the details of a significant stock option grant, is common practice in the technology sector to incentivize leadership and align interests with long-term company performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| 10b5-1 Trading Plan | Transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | Not specified, but implied to be in effect for the 04/24/2026 transaction. | Enhances transparency and provides a defense against insider trading allegations for planned transactions. |
Stakeholder Impact
- Shareholders: The acquisition by the CEO may be viewed positively as a sign of confidence. The out-of-the-money options suggest potential future upside is expected by management.
- Employees: The vesting schedule of the stock options provides a long-term incentive for employees, aligning their efforts with the company's stock performance.
- Management: The stock option grant serves as a key component of executive compensation, incentivizing performance and retention.
Next Steps
- Continued vesting of stock options according to the schedule (January 1, April 1, July 1, October 1).
- Potential exercise of stock options if the stock price reaches or exceeds $23.00 before the expiration date of October 1, 2031.
Key Dates
| Date | Description |
|---|---|
| 10/01/2021 | Date of stock option grant. |
| 10/01/2022 | First vesting date for a portion of the stock option. |
| 04/24/2026 | Transaction date for the acquisition of 2,000 common shares. |
| 04/27/2026 | Date the Form 4 was signed. |
| 10/01/2031 | Expiration date of the stock option. |
Keywords
SEC Form 4, Insider Trading, Stock Acquisition, Stock Options, Beneficial Ownership, Exzeo Group, Paresh Patel, Executive Compensation, Vesting Schedule
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.